Through ChIP and dual-luciferase reporter assays, we found that Sox2 acts as a transcription factor for UPF1, and the overexpression of Sox2 in endometrial cancer non-stem cells and ECSCs can increase the expression of UPF1. The gene discussed is UPF1; the disease is endometrial cancer.